Testing effectiveness (Phase 2)Study completedNCT03058692
What this trial is testing
Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine
Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 120